Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01530204 · ClinicalTrials.gov registry record · Phase 4
RAPID: Reducing Pain; Preventing Depression
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 135
- Enrollment target
NCT01530204: Completed Phase 4 study, sponsored by University of Pittsburgh.
NCT01530204 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 135 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01530204, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 135 participants
- Enrollment target
Study Summary
The primary question addressed by this prevention study is to explore if improving pain and disability reduces episodes of Major Depression among seniors with knee osteoarthritis (OA) and mild depressive symptoms.
Interventions
- OTHER Enhanced Treatment as Usual
- PROCEDURE Physical Therapy for knee OA
- BEHAVIORAL Cognitive Behavioral Therapy for Pain CBT-P
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2011-07 |
| Est. Completion | 2016-03 |
| Phase | Phase 4 |
What the finished NCT01530204 record still lists
NCT01530204 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 3 interventions - of which Enhanced Treatment as Usual is the first listed.
NCT01530204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01530204 about?
NCT01530204 is a clinical study titled "RAPID: Reducing Pain; Preventing Depression". The primary question addressed by this prevention study is to explore if improving pain and disability reduces episodes of Major Depression among seniors with knee osteoarthritis (OA) and mild depressive symptoms.
What is the current status of trial NCT01530204?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 135 participants. The study started on 2011-07. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01530204?
The interventions under investigation include: Enhanced Treatment as Usual (OTHER), Physical Therapy for knee OA (PROCEDURE), Cognitive Behavioral Therapy for Pain CBT-P (BEHAVIORAL).
Who is sponsoring clinical trial NCT01530204?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01530204's enrollment target sits among peer trials
135 601st of 2000 higher than 1,395 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia